Cargando…
Changes in subcellular localisation of MI-ER1α, a novel oestrogen receptor-α interacting protein, is associated with breast cancer progression
The oestrogen receptor-α (ERα) plays a key role in breast development and tumorigenesis and inhibiting its activity remains a prime strategy in the treatment of ERα-positive breast cancers. Thus, elucidation of the molecular mechanisms responsible for regulating ERα activity may facilitate the desig...
Autores principales: | McCarthy, P L, Mercer, F C, Savicky, M W J, Carter, B A, Paterno, G D, Gillespie, L L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527822/ https://www.ncbi.nlm.nih.gov/pubmed/18665173 http://dx.doi.org/10.1038/sj.bjc.6604518 |
Ejemplares similares
-
Oestrogen receptor-α contributes to the regulation of the hedgehog signalling pathway in ERα-positive gastric cancer
por: Kameda, C, et al.
Publicado: (2010) -
Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours
por: Skliris, G P, et al.
Publicado: (2006) -
The clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers
por: Nakano, J, et al.
Publicado: (2008) -
Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of β-catenin in ovarian tumours
por: Wang, Y, et al.
Publicado: (2006) -
Serum oestrogen receptor α and β bioactivity are independently associated with breast cancer: a proof of principle study
por: Widschwendter, M, et al.
Publicado: (2009)